Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs that interact with immunosuppressive agents

J F Trotter1

  • 1Division of Gastroenterology, Duke University Medical Center, Durham, NC 27710, USA.

Seminars in Gastrointestinal Disease
|August 13, 1998
PubMed
Summary

Liver transplant recipients frequently experience drug interactions, especially with immunosuppressants like cyclosporin A. Managing these interactions is crucial for patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Living Donor Collective: A Scientific Registry for Living Donors.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Editorial for Neuroendocrine Tumor for Liver Transplant.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

The INR is only one side of the coagulation cascade: time to watch the clot.

Anaesthesia·2016
Same author

Sotrastaurin in liver transplantation: has it had a fair trial?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Auxiliary liver transplant is an ineffective treatment of primary hyperoxaluria.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Area of Science:

  • Pharmacology
  • Transplantation Medicine
  • Clinical Pharmacy

Background:

  • Liver transplant recipients often require multiple medications, increasing the risk of drug interactions.
  • Immunosuppressive agents are essential but commonly involved in significant drug interactions.
  • Cyclosporin A is a frequently prescribed immunosuppressant with a high incidence of reported drug interactions.

Purpose of the Study:

  • To review clinically significant drug interactions involving commonly prescribed immunosuppressants in liver transplant recipients.
  • To highlight the prevalence and nature of drug interactions in this patient population.

Main Methods:

  • Literature review of reported drug interactions in liver transplant recipients.
  • Focus on interactions involving commonly used immunosuppressive medications.

Main Results:

  • Clinically significant drug interactions are common in liver transplant recipients.
  • Most reported interactions involve cyclosporin A.
  • Concurrent use of immunosuppressants and other medications contributes to interaction risks.

Conclusions:

  • Effective management of drug interactions is vital for liver transplant recipients.
  • Awareness of cyclosporin A interactions is particularly important.
  • Further research and clinical vigilance are needed to optimize medication therapy.

Related Experiment Videos